propoxyphene napsylate and acetaminophen tablet
redpharm drug inc. - propoxyphene napsylate (unii: 38m219l1oj) (propoxyphene - unii:s2f83w92tk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) -
dextropropoxyphene paracetamol arrow 30 mg/400 mg, gélule
arrow generiques - chlorhydrate de dextropropoxyphène - gélule - 30 mg - composition pour une gélule > chlorhydrate de dextropropoxyphène : 30 mg > paracétamol : 400 mg - analgesiques opioides
dextropropoxyphene paracetamol g gam 30 mg/400 mg, gélule
sandoz - chlorhydrate de dextropropoxyphène - gélule - 30 mg - composition pour une gélule > chlorhydrate de dextropropoxyphène : 30 mg > paracétamol : 400 mg - antalgiques peripheriques/opioides.
dextropropoxyphene paracetamol ivax 30 mg/400 mg, gélule
teva sante - chlorhydrate de dextropropoxyphène - gélule - 30 mg - composition pour une gélule > chlorhydrate de dextropropoxyphène : 30 mg > paracétamol : 400 mg - antalgiques peripheriques/opioides.
dextropropoxyphene paracetamol biogaran 30 mg/400 mg, gélule
biogaran - chlorhydrate de dextropropoxyphène - gélule - 30 mg - composition pour une gélule > chlorhydrate de dextropropoxyphène : 30 mg > paracétamol : 400 mg - antalgiques peripheriques/opioides.
dextropropoxyphene paracetamol mylan 30 mg/400 mg, gélule
mylan sas - chlorhydrate de dextropropoxyphène - gélule - 30 mg - composition pour une gélule > chlorhydrate de dextropropoxyphène : 30 mg > paracétamol : 400 mg - antalgiques peripheriques/opioides.
dextropropoxyphene paracetamol teva 30 mg/400 mg, gélule
teva sante - chlorhydrate de dextropropoxyphène - gélule - 30 mg - composition pour une gélule > chlorhydrate de dextropropoxyphène : 30 mg > paracétamol : 400 mg - antalgiques peripheriques/opioides.
naloxone hydrochloride- naloxone hydrochloride injection, solution
general injectables & vaccines, inc - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride 0.4 mg in 1 ml - naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and cyclazocine. naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage. naloxone may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see clinical pharmacology, adjunctive use in septic shock). naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients contained in the formulation. naloxone hydrochloride injection is an opioid antagonist. physical dependence associated with the use of naloxone hydrochloride injection has not been reported. tolerance to the opioid antagonist effect of naloxone is not known to occur.
naloxone hydrochloride- nalxone hydrochloride injection
hikma pharmaceuticals usa inc. - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride 0.4 mg in 1 ml - naloxone hydrochloride injection, usp is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine. naloxone hydrochloride injection, usp is also indicated for diagnosis of suspected or known acute opioid overdosage. naloxone hydrochloride injection, usp may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see clinical pharmacology; adjunctive use in septic shock ). naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients in naloxone hydrochloride injection. naloxone hydrochloride injection is an opioid antagonist. physical dependence associated with the use of naloxone hydrochloride injection has not been reported. tolerance to the opioid antagonist
naloxone hydrochloride- naloxone hydrochloride injection, solution
cardinal health - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride 0.4 mg in 1 ml - naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and cyclazocine. naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage. naloxone may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see clinical pharmacology, adjunctive use in septic shock). naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients contained in the formulation. naloxone hydrochloride injection is an opioid antagonist. physical dependence associated with the use of naloxone hydrochloride injection has not been reported. tolerance to the opioid antagonist effect of naloxone is not known to occur.